Inactive Instrument

SMITH & NEPHEW Share Price Swiss Exchange

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

End-of-day quote Swiss Exchange
- GBX - Intraday chart for SMITH & NEPHEW
Sales 2024 * 581.34Cr 49TCr Sales 2025 * 612.39Cr 51TCr Capitalization 1.18TCr 99TCr
Net income 2024 * 53Cr 4.39TCr Net income 2025 * 69Cr 5.74TCr EV / Sales 2024 * 2.48 x
Net Debt 2024 * 261.36Cr 22TCr Net Debt 2025 * 229.82Cr 19TCr EV / Sales 2025 * 2.3 x
P/E ratio 2024 *
21.3 x
P/E ratio 2025 *
16.1 x
Employees -
Yield 2024 *
2.76%
Yield 2025 *
3.09%
Free-Float 99.15%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 01/22/01
Director of Finance/CFO 56 01/12
Compliance Officer - 01/99/01
Members of the board TitleAgeSince
Director/Board Member 65 01/17/01
Director/Board Member 62 14/23/14
Chairman 63 26/23/26
More insiders
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
Calendar
More about the company